← Back to Search

Social Media Strategy for COVID-19 Vaccination Equity

N/A

Waitlist Available

Led By Damon Centola, PhD

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 18 and above

Be older than 18 years old

Must not have

Aged below 18

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediate after intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial is using social media to try and bridge the digital divide in social technology between African American and Latinx populations and white and Asian members of online communities.

Who is the study for?

This trial is for adults over 18 living in the United States with internet access. It aims to improve health equity and COVID-19 vaccination rates among at-risk populations, particularly addressing challenges faced by African American and Latinx communities.

What is being tested?

The study tests an online social network intervention designed to reduce digital divide and increase engagement with health-promoting information. Participants will be compared to a control group without this intervention.

What are the potential side effects?

Since this trial involves an online social network intervention rather than a medical treatment, traditional physical side effects are not expected. However, participants may experience changes in their online interactions or exposure to information.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am under 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediate after intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediate after intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediate after intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

COVID-19 vaccination attitude

COVID-19 vaccination intention

COVID-19 vaccine safety perception

Secondary study objectives

COVID-19 vaccine belief

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

6Treatment groups

Experimental Treatment

Group I: Independent Control of Homogeneous PopulationsExperimental Treatment1 Intervention

Independent control condition does not have online networks. Participants in this condition are not put into online networks. Participants only respond to questions by themselves. All participants in this condition share similar baseline demographic characteristics, attitudes, or behavioral choices.

Group II: Independent Control of Diverse PopulationsExperimental Treatment1 Intervention

Independent control condition does not have online networks. Participants in this condition are not put into online networks. Participants only respond to questions by themselves. All participants in this condition have very different baseline demographic characteristics, attitudes, or behavioral choices.

Group III: Egalitarian Networks of Homogeneous PopulationsExperimental Treatment1 Intervention

Egalitarian networks are characterized by equal connectivity for all participants in an online network for information exchange. Each network is consisted of 40 individual participants. All network participants in this condition share similar baseline demographic characteristics, attitudes, or behavioral choices.

Group IV: Egalitarian Networks of Diverse PopulationsExperimental Treatment1 Intervention

Egalitarian networks are characterized by equal connectivity for all participants in an online network for information exchange. Each network is consisted of 40 individual participants. All network participants in this condition have very different baseline demographic characteristics, attitudes, or behavioral choices.

Group V: Centralized Networks of Homogeneous PopulationsExperimental Treatment1 Intervention

Centralized networks have a small number of influential individuals, called "hubs," with connections to most other people. Centralized networks characterize situations in which most or all individuals are connected to, and seek advice from, a few well-connected "influencers." Each network is consisted of 40 individual participants. All network participants in this condition share similar baseline demographic characteristics, attitudes, or behavioral choices.

Group VI: Centralized Networks of Diverse PopulationsExperimental Treatment1 Intervention

Centralized networks have a small number of influential individuals, called "hubs," with connections to most other people. Centralized networks characterize situations in which most or all individuals are connected to, and seek advice from, a few well-connected "influencers." Each network is consisted of 40 individual participants. All network participants in this condition have very different baseline demographic characteristics, attitudes, or behavioral choices.

0 / 2Eligibility criteria met